Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neovascular AMD”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03479372
What this trial is testing

Study of PAN-90806 Eye Drops, Suspension for Neovascular AMD

Who this might be right for
Neovascular Age-related Macular Degeneration
PanOptica, Inc. 51
Not applicableStudy completedNCT05834075
What this trial is testing

A Retrospective Study to Evaluate the Early Real-world Evidence of Brolucizumab in Patients With Neovascular Age-related Macular Degeneration (nAMD) in India

Who this might be right for
Neurovascular Age-related Macular Degeneration
Novartis Pharmaceuticals 63
Not applicableStudy completedNCT01942213
What this trial is testing

Observational Study to Evaluate and Compare the Rate and Extent of Inflammation After a Single Intravitreal Injection of Ranibizumab vs. a Single Intravitreal Injection of Aflibercept in Treatment Naive and Treatment Experienced Patients.

Who this might be right for
Neovascular Age Related Macular Degeneration
Prism Vision Group 136
Testing effectiveness (Phase 2)Study completedNCT04304755
What this trial is testing

Zoledronic Acid as Adjuvant Therapy in Neovascular Age-related Macular Degeneration (Z-AMD)

Who this might be right for
Neovascular Age-related Macular Degeneration
Oslo University Hospital 40
Testing effectiveness (Phase 2)WithdrawnNCT02511613
What this trial is testing

Effect of Squalamine Lactate Ophthalmic Solution, 0.2% in Subjects With Neovascular Age-Related Macular Degeneration

Who this might be right for
Age-Related Macular Degeneration
Ohr Pharmaceutical Inc.
Not applicableStudy completedNCT05657158
What this trial is testing

Analysis of Imaging Features From Patients Treated With Brolucizumab in the Post-marketing Setting With Reports of Retinal Vasculitis and/or Retinal Vascular Occlusion

Who this might be right for
Intraocular InflammationRetinal Vascular Occlusion
Novartis Pharmaceuticals 198
Not applicableNot Yet RecruitingNCT05507840
What this trial is testing

Photobiomodulation for Dry Age Related Macula Degeneration

Who this might be right for
PhotobiomodulationAge-Related Macular Degeneration
Oslo University Hospital 121
Testing effectiveness (Phase 2)Ended earlyNCT00464347
What this trial is testing

TAC-PF, Avastin® in Combination With Photodynamic Therapy to Treat Age Related Macular Degeneration

Who this might be right for
Age-Related Macular Degeneration
National Eye Institute (NEI) 100
Testing effectiveness (Phase 2)Looking for participantsNCT06659549
What this trial is testing

Efficacy and Safety Study of GAL-101, 2% Ophthalmic Solution in Non-foveal Geographic Atrophy Secondary to Non-neovascular AMD

Who this might be right for
Geographic Atrophy of the Macula
Galimedix Therapeutics Inc 110
Testing effectiveness (Phase 2)UnknownNCT02067013
What this trial is testing

Analysis of Aqueous and Vitreous Humor

Who this might be right for
Proliferative Diabetic RetinopathyMacular DegenerationMacular Hole+1 more
California Retina Consultants 45
Large-scale testing (Phase 3)Study completedNCT00531024
What this trial is testing

Systemic Avastin Therapy in Age-Related Macular Degeneration

Who this might be right for
Macular Degeneration
The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery 30
Early research (Phase 1)Study completedNCT07484074
What this trial is testing

A Phase 1b Study to Assess the Safety, Tolerability, Pharmacokinetics, and Exploratory Efficacy of Intravitreal OLN324

Who this might be right for
Diabetic Macular Edema (DME)Neovascular (Wet) Age-Related Macular Degeneration
Ollin Biosciences, Inc. 164
Large-scale testing (Phase 3)Ended earlyNCT03710564
What this trial is testing

Study of Safety and Efficacy of Brolucizumab 6 mg Dosed Every 4 Weeks Compared to Aflibercept 2 mg Dosed Every 4 Weeks in Patients With Retinal Fluid Despite Frequent Anti-VEGF Injections

Who this might be right for
Age-Related Macular Degeneration
Novartis Pharmaceuticals 535
Testing effectiveness (Phase 2)Study completedNCT01494805
What this trial is testing

Safety and Efficacy Study of rAAV.sFlt-1 in Patients With Exudative Age-Related Macular Degeneration

Who this might be right for
Macular DegenerationAge-related MaculopathiesAge-related Maculopathy+5 more
Lions Eye Institute, Perth, Western Australia 40
Not applicableStudy completedNCT03744806
What this trial is testing

Blood-aqueous Barrier Integrity in Eyes Undergoing Intravitreal Bevacizumab Therapy to Treat Neovascular AMD

Who this might be right for
Exudative Age-related Macular Degeneration
Medical University of Lublin 48
Large-scale testing (Phase 3)Looking for participantsNCT07007065
What this trial is testing

Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD)

Who this might be right for
Neovascular Age-related Macular Degeneration
AbbVie 561
Testing effectiveness (Phase 2)Study completedNCT03216538
What this trial is testing

Safety and Efficacy of AS101 1% Oral Solution in Patients With Neovascular Age-Related Macular Degeneration (AMD)

Who this might be right for
Neovascular Age-related Macular Degeneration
Feramda 20
Large-scale testing (Phase 3)Study completedNCT05587062
What this trial is testing

Efficacy and Safety of Aflibercept in Patients With Neovascular Age-related Macular Degeneration

Who this might be right for
Age-Related Macular DegenerationNeovascular Age-related Macular Degeneration
Cinnagen 168
Large-scale testing (Phase 3)Study completedNCT03150589
What this trial is testing

Compare SB11 (Proposed Ranibizumab Biosimilar) to Lucentis in Subjects With Neovascular Age-related Macular Degeneration (AMD)

Who this might be right for
Age-Related Macular Degeneration
Samsung Bioepis Co., Ltd. 705
Large-scale testing (Phase 3)Study completedNCT04423718
What this trial is testing

Study of the Effects of High Dose Aflibercept Injected Into the Eye of Patients With an Age-related Disorder That Causes Loss of Vision Due to Growth of Abnormal Blood Vessels at the Back of the Eye

Who this might be right for
Neovascular Age-Related Macular Degeneration
Bayer 1,011
Next Page